As of 2025-01-13, the Relative Valuation of Biogen Inc (BIIB) is 284.87 USD. This relative valuation is based on P/E multiples. With the latest stock price at 150.18 USD, the upside of Biogen Inc based on Relative Valuation is 89.7%.
The range of the Relative Valuation is 193.54 - 354.47 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.9x - 32.0x | 26.9x |
| Forward P/E multiples | 24.5x - 44.5x | 34.4x |
| Fair Price | 193.54 - 354.47 | 284.87 |
| Upside | 28.9% - 136.0% | 89.7% |
| Date | P/E |
| 2025-01-13 | 13.55 |
| 2025-01-10 | 13.43 |
| 2025-01-08 | 13.60 |
| 2025-01-07 | 13.82 |
| 2025-01-06 | 13.83 |
| 2025-01-03 | 13.73 |
| 2025-01-02 | 13.53 |
| 2024-12-31 | 13.80 |
| 2024-12-30 | 13.55 |
| 2024-12-27 | 13.65 |
| 2024-12-26 | 13.52 |
| 2024-12-24 | 13.44 |
| 2024-12-23 | 13.48 |
| 2024-12-20 | 13.21 |
| 2024-12-19 | 13.30 |
| 2024-12-18 | 13.24 |
| 2024-12-17 | 13.59 |
| 2024-12-16 | 13.58 |
| 2024-12-13 | 13.54 |
| 2024-12-12 | 14.01 |
| 2024-12-11 | 14.21 |
| 2024-12-10 | 14.10 |
| 2024-12-09 | 14.12 |
| 2024-12-06 | 14.23 |
| 2024-12-05 | 14.37 |
| 2024-12-04 | 14.52 |
| 2024-12-03 | 14.51 |
| 2024-12-02 | 14.82 |
| 2024-11-29 | 14.49 |
| 2024-11-27 | 14.42 |
| 2024-11-26 | 14.23 |
| 2024-11-25 | 14.32 |
| 2024-11-22 | 14.25 |
| 2024-11-21 | 14.26 |
| 2024-11-20 | 14.07 |
| 2024-11-19 | 14.02 |
| 2024-11-18 | 14.25 |
| 2024-11-15 | 14.43 |
| 2024-11-14 | 14.88 |
| 2024-11-13 | 14.96 |
| 2024-11-12 | 15.18 |
| 2024-11-11 | 15.52 |
| 2024-11-08 | 15.61 |
| 2024-11-07 | 15.69 |
| 2024-11-06 | 15.73 |
| 2024-11-05 | 15.96 |
| 2024-11-04 | 15.65 |
| 2024-11-01 | 15.68 |
| 2024-10-31 | 15.70 |
| 2024-10-30 | 16.35 |